Education
About Us
Working with TipRanks
Follow Us
AstraZeneca plc (CH:ZEG)
:ZEG
Total Valuation
AstraZeneca has a market cap or net worth of CHF183.04B. The enterprise value is CHF196.08B.
Market CapCHF183.04B
Enterprise ValueCHF196.08B
Share Statistics
AstraZeneca has 1,550,623,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,550,623,500
Owned by Insiders0.03%
Owned by Institutions0.01%
Financial Efficiency
AstraZeneca’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 10.30%.
Return on Equity (ROE)0.17
Return on Assets (ROA)0.07
Return on Invested Capital (ROIC)10.30%
Return on Capital Employed (ROCE)0.13
Revenue Per Employee573.41K
Profits Per Employee92.16K
Employee Count94,300
Asset Turnover0.52
Inventory Turnover1.93
Valuation Ratios
The current PE Ratio of AstraZeneca is 28.93. AstraZeneca’s PEG ratio is 1.53.
PE Ratio28.93
PS Ratio0.00
PB Ratio4.99
Price to Fair Value4.99
Price to FCF27.98
Price to Operating Cash Flow17.16
PEG Ratio1.53
Income Statement
In the last 12 months, AstraZeneca had revenue of 54.07B and earned 7.04B in profits. Earnings per share was 4.53.
Revenue54.07B
Gross Profit43.87B
Operating Income10.00B
Pretax Income8.69B
Net Income7.04B
EBITDA17.12B
Earnings Per Share (EPS)4.53
Cash Flow
In the last 12 months, operating cash flow was 11.86B and capital expenditures -4.59B, giving a free cash flow of 7.28B billion.
Operating Cash Flow11.86B
Free Cash Flow7.28B
Free Cash Flow per Share4.69
Dividends & Yields
AstraZeneca pays an annual dividend of CHF2.709, resulting in a dividend yield of 2.31%
Dividend Per ShareCHF2.709
Dividend Yield2.31%
Payout Ratio25.88%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.06
52-Week Price Change0.00%
50-Day Moving Average121.57
200-Day Moving Average121.57
Relative Strength Index (RSI)100.00
Average Volume (3m)0.00
Important Dates
AstraZeneca upcoming earnings date is Jul 24, 2025, TBA Not Confirmed.
Last Earnings DateApr 29, 2025
Next Earnings DateJul 24, 2025
Ex-Dividend DateFeb 20, 2025
Financial Position
AstraZeneca as a current ratio of 0.93, with Debt / Equity ratio of 73.83%
Current Ratio0.93
Quick Ratio0.74
Debt to Market Cap0.14
Net Debt to EBITDA1.44
Interest Coverage Ratio5.74
Taxes
In the past 12 months, AstraZeneca has paid 1.65B in taxes.
Income Tax1.65B
Effective Tax Rate0.19
Enterprise Valuation
AstraZeneca EV to EBITDA ratio is 13.33, with an EV/FCF ratio of 31.36.
EV to Sales4.22
EV to EBITDA13.33
EV to Free Cash Flow31.36
EV to Operating Cash Flow19.24
Balance Sheet
AstraZeneca has CHF5.65B in cash and marketable securities with $30.11B in debt, giving a net cash position of CHF24.46B billion.
Cash & Marketable SecuritiesCHF5.65B
Total Debt$30.11B
Net CashCHF24.46B
Net Cash Per ShareCHF15.77
Tangible Book Value Per Share-CHF11.15
Margins
Gross margin is 81.12%, with operating margin of 18.50%, and net profit margin of 13.01%.
Gross Margin81.12%
Operating Margin18.50%
Pretax Margin16.07%
Net Profit Margin13.01%
EBITDA Margin31.66%
EBIT Margin19.29%
Analyst Forecast
The average price target for AstraZeneca is CHF147.81, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF147.81
Price Target Upside21.59% Upside
Analyst ConsensusModerate Buy
Analyst Count14
Revenue Growth Forecast―
EPS Growth Forecast―